An 0 2 0 2 O
infarct 3 10 3 10 O
- 10 11 10 11 O
like 11 15 11 15 O
lesion 16 22 16 22 O
is 23 25 23 25 O
defined 26 33 26 33 O
as 34 36 34 36 O
an 37 39 37 39 O
MRI 40 43 40 43 O
signal 44 50 44 50 O
abnormality 51 62 51 62 O
that 63 67 63 67 O
is 68 70 68 70 O
at 71 73 71 73 O
least 74 79 74 79 O
3 80 81 80 81 B-lower_bound
mm 82 84 82 84 I-lower_bound
in 85 87 85 87 O
one 88 91 88 91 O
dimension 92 101 92 101 O
and 102 105 102 105 O
that 106 110 106 110 O
is 111 113 111 113 O
visible 114 121 114 121 O
in 122 124 122 124 O
two 125 128 125 128 O
planes 129 135 129 135 O
on 136 138 136 138 O
fluid 139 144 139 144 O
- 144 145 144 145 O
attenuated 145 155 145 155 O
inversion 156 165 156 165 O
recovery 166 174 166 174 O
( 175 176 175 176 O
FLAIR 176 181 176 181 O
) 181 182 181 182 O
T2 183 185 183 185 O
- 185 186 185 186 O
weighted 186 194 186 194 O
images 195 201 195 201 O
, 201 202 201 202 O
as 203 205 203 205 O
determined 206 216 206 216 O
by 217 219 217 219 O
a 220 221 220 221 O
neuroradiologist 222 238 222 238 O

Clinically 0 10 239 249 O
significant 11 22 250 261 O
neurologic 23 33 262 272 B-chronic_disease
event 34 39 273 278 I-chronic_disease
( 40 41 279 280 I-chronic_disease
stroke 41 47 280 286 I-chronic_disease
) 47 48 286 287 I-chronic_disease
or 49 51 288 290 O
any 52 55 291 294 O
neurologic 56 66 295 305 O
deficit 67 74 306 313 O
lasting 75 82 314 321 O
> 83 84 322 323 O
24 84 86 323 325 B-lower_bound
hours 87 92 326 331 I-lower_bound
that 93 97 332 336 O
is 98 100 337 339 O
accompanied 101 112 340 351 O
by 113 115 352 354 O
an 116 118 355 357 O
infarct 119 126 358 365 O
on 127 129 366 368 O
cerebral 130 138 369 377 B-treatment
MRI 139 142 378 381 I-treatment

Females 0 7 382 389 B-gender
who 8 11 390 393 O
are 12 15 394 397 O
pregnant 16 24 398 406 B-pregnancy

Patient 0 7 407 414 O
must 8 12 415 419 O
be 13 15 420 422 O
between 16 23 423 430 O
18 24 26 431 433 B-lower_bound
and 27 30 434 437 O
34.99 31 36 438 443 B-upper_bound
years 37 42 444 449 I-upper_bound
of 43 45 450 452 O
age 46 49 453 456 B-age

Patients 0 8 457 465 O
must 9 13 466 470 O
demonstrate 14 25 471 482 O
one 26 29 483 486 O
or 30 32 487 489 O
more 33 37 490 494 O
of 38 40 495 497 O
the 41 44 498 501 O
following 45 54 502 511 O
Sickle 55 61 512 518 B-chronic_disease
Cell 62 66 519 523 I-chronic_disease
Disease 67 74 524 531 I-chronic_disease
Complications 75 88 532 545 O
( 89 90 546 547 O
or 90 92 547 549 O
patients 93 101 550 558 O
in 102 104 559 561 O
Cohort 105 111 562 568 O
2 112 113 569 570 O
can 114 117 571 574 O
meet 118 122 575 579 O
other 123 128 580 585 O
high 129 133 586 590 O
risk 134 138 591 595 O
criteria 139 147 596 604 O
instead 148 155 605 612 O
) 155 156 612 613 O

Patients 0 8 614 622 O
who 9 12 623 626 O
have 13 17 627 631 O
previously 18 28 632 642 O
received 29 37 643 651 O
a 38 39 652 653 O
HSCT 40 44 654 658 B-treatment
will 45 49 659 663 O
not 50 53 664 667 O
be 54 56 668 670 O
eligible 57 65 671 679 O

Patients 0 8 680 688 O
with 9 13 689 693 O
contraindications 14 31 694 711 O
to 32 34 712 714 O
the 35 38 715 718 O
use 39 42 719 722 O
of 43 45 723 725 O
defibrotide 46 57 726 737 B-allergy_name

Recurrent 0 9 738 747 O
painful 10 17 748 755 O
events 18 24 756 762 O
( 25 26 763 764 O
at 26 28 764 766 O
least 29 34 767 772 O
3 35 36 773 774 B-lower_bound
in 37 39 775 777 O
the 40 43 778 781 O
2 44 45 782 783 B-upper_bound
years 46 51 784 789 I-upper_bound
prior 52 57 790 795 I-upper_bound
to 58 60 796 798 O
enrollment 61 71 799 809 O
or 72 74 810 812 O
prior 75 80 813 818 O
to 81 83 819 821 O
chronic 84 91 822 829 O
chronic 92 99 830 837 O
RBC 100 103 838 841 B-treatment
transfusion 104 115 842 853 I-treatment
therapy 116 123 854 861 I-treatment
, 123 124 861 862 O
exchange 125 133 863 871 B-treatment
transfusion 134 145 872 883 I-treatment
or 146 148 884 886 O
erythrocyte 149 160 887 898 O
pheresis 161 169 899 907 B-treatment
) 169 170 907 908 O

SCD 0 3 909 912 B-chronic_disease
Patients 4 12 913 921 O
with 13 17 922 926 O
documented 18 28 927 937 O
uncontrolled 29 41 938 950 B-chronic_disease
infection 42 51 951 960 I-chronic_disease
at 52 54 961 963 O
the 55 58 964 967 O
time 59 63 968 972 O
of 64 66 973 975 O
study 67 72 976 981 O
entry 73 78 982 987 O
are 79 82 988 991 O
not 83 86 992 995 O
eligible 87 95 996 1004 O

WBC 0 3 1005 1008 B-clinical_variable
> 4 5 1009 1010 O
13,500 6 12 1011 1017 B-lower_bound
cells 13 18 1018 1023 I-lower_bound
/ 18 19 1023 1024 I-lower_bound
microliter 19 29 1024 1034 I-lower_bound
at 30 32 1035 1037 O
baseline 33 41 1038 1046 O
when 42 46 1047 1051 O
not 47 50 1052 1055 O
acutely 51 58 1056 1063 O
ill 59 62 1064 1067 O
( 63 64 1068 1069 O
on 64 66 1069 1071 O
two 67 70 1072 1075 O
separate 71 79 1076 1084 O
occasions 80 89 1085 1094 O
) 89 90 1094 1095 O
> 91 92 1096 1097 O
2 93 94 1098 1099 B-lower_bound
weeks 95 100 1100 1105 I-lower_bound
from 101 105 1106 1110 O
a 106 107 1111 1112 O
VOC 108 111 1113 1116 O
event 112 117 1117 1122 O
or 118 120 1123 1125 O
hospitalization 121 136 1126 1141 O

all 0 3 1142 1145 O
patients 4 12 1146 1154 O
must 13 17 1155 1159 O
meet 18 22 1160 1164 O
disease 23 30 1165 1172 O
, 30 31 1172 1173 O
age 32 35 1174 1177 B-age
, 35 36 1177 1178 O
organ 37 42 1179 1184 O
function 43 51 1185 1193 O
and 52 55 1194 1197 O
donor 56 61 1198 1203 O
criteria 62 70 1204 1212 O

